Epidemiology of inflammatory bowel disease: Controversies in classical epidemiology;Enfermedad de Crohn y colitis ulcerosa: Discusión de la epidemiología clásica

Acta Gastroenterologica Latinoamericana

Volumn 39, Issue 2, 2009, Pages 135-145

  Sicilia, Beatriz ^a   Vicente, Raquel ^b   Gomollón, Fernando ^c,d  

^a Hospital de Alcañiz Alcañiz   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Crohn's disease; Epidemiology; Natural history; Risk factors; Ulcerative colitis

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT;

APPENDECTOMY; BEHAVIOR; CHILDHOOD; CHRONIC INFLAMMATION; COLORECTAL CANCER; CROHN DISEASE; DIAGNOSTIC PROCEDURE; DIET; ENTERITIS; ENVIRONMENT; GENE; HUMAN; HYGIENE; INFECTION; MORBIDITY; MORTALITY; POPULATION; PREVALENCE; REVIEW; RISK FACTOR; SMOKING; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INCIDENCE; PREVALENCE; RISK FACTORS;

EID: 68249160974     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Sandler RS. Epidemiology of the Inflammatory Bowel Disease. In: Targan SR, Shanahan F editors. Inflammatory Bowel Disease from bench to bedside. Baltimore (MD): Williams and Wilkins; 1994.p5-32.
2. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC- IBD). Gut 1996;39:690-697. (Pubitemid 26426470)
3. Bach JF. The effects of infections on susceptibility to autoimmune and allergic diseases. N Engl Med 2002;347:911-920.
4. Blanchard JF, Bernstein CN, Wajda A and Rawsthorne P. Small area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-335. (Pubitemid 32756629)
5. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-1517. (Pubitemid 38649869)
6. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Inflammatory bowel disease: re-evaluation of the diagnosis in a prospective population based study in south eastern Norway. Gut 1997;40:328-332. (Pubitemid 27145644)
7. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998;114:1161-1168.
8. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival. Gut 2000;46;336-343.
9. Loftus CG, Loftus EV, Harmsen WS, Zinsmeister AR, Tremaine WJ, Melton LJ, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007;13:254-261.
10. Bernstein CN, Blanchard JF, Rawsthorne P and Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916-924. (Pubitemid 29230706)
11. Bernstein CN, Wajda A, Svenson L, MacKenzie A, Koehoorn M, Jackson M, et al. The epidemiology of inflammatory bowel disease in Canada: a population based study. Am J Gastroenterol 2006;101:1559-1568. (Pubitemid 43980630)
12. Appleyard CB, Hernandez G, Rios-Bedova CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis 2004;10:106-111. (Pubitemid 38332169)
13. Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-1438.
14. Latour P, Louis E, Belaiche J. Incidence of inflammatory bowel disease in the area of Liege: a 3 years prospective study (1993-1996). Acta Gastroenterol Belg 1998;61:410-413.
15. Abakar-Mahamat A, Filippi J, Pradier C, Dozol A, Hébuterne X. Incidence of inflammatory bowel disease in Corsica from 2002 to 2003. Gastroenterol Clin Biol 2007;31:1098-1103.
16. Manousos ON, Giannadaki E, Mouzas IA, Tzardi M, Koutroubakis I, Skordilis P, et al. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol 1996;8:893-898. (Pubitemid 26319393)
17. Manousos ON, Koutroubakis I, Potamianos S, Roussomoustakaki M, Gourtsoyiannis N, Vlachonikolis IG. A prospective epidemiologic study of Crohn's disease in Heraklion, Crete. Incidence over a 5-year period. Scand J Gastroenterol 1996;31:599-603. (Pubitemid 26196142)
18. Ladas SD, Mallas E, Giorgiotis K, Karamanolis G, Trigonis D, Markadas A, et al. Incidence of ulcerative colitis in Central Greece: a prospective study. World J Gastroenterol 2005;11:1785-1787. (Pubitemid 40520768)
19. Van Gossum A, Adler M, De Reuck, Devis G, Fiasse R, Vanheurverzwijn R, et al. Epidemiology of inflammatory bowel disease in Brussels' area (1992-1993). Acta Gastroenterol Belg 1996;59:7-9.
20. Russel MG, Dorant E, Volovics A, Brummer RJ, Pop P, Muris JW, et al. High incidence of inflammatory bowel disease in The Netherlands: results of a prospective study. The South Limburg IBD Study Group. Dis Colon Rectum 1998;41:33-40. (Pubitemid 28044873)
21. Ruiz Ochoa V. Estudio epidemiológico de la enfermedad de Crohn en Galicia en el período de 1976 a 1983. Rev Esp Enf Ap Digest 1984;66:273-279.
22. Brullet E, Bonfill X, Urrutia G, Ruiz Ochoa V, Cueto M. Estudio epidemiológico sobre la incidencia de enfermedad inflamatoria intestinal en cuatro áreas españolas. Med Clin 1998;110:651-656. (Pubitemid 128530184)
23. Gomollón F, López J, Sainz R. High incidence of inflammatory bowel disease in Aragón (Spain): a prospective population based study. Gastroenterology 1995;(supl)108:A865.
24. López Miguel C, Sicilia B, Sierra E, López Zaborras J, Arribas F, Gomollon F. Incidence of inflammatory bowel disease in Aragón: outcome of a prospective population-based study. Gastroenterol Hepatol 1999;22:323-328.
25. Saro Gismera C, Lacort Fernández M, Argüelles Fernández G, Antón Magarzo J, García López R, Navascues C, et al. Incidencia y prevalencia de la enfermedad Inflamatoria Intestinal Crónica en Gijón. Asturias. Gastroenterol y Hepatol 2000;23:322-327.
26. Saro Gismera C C, de la Coba, M. Lacort Fernández, A. González Bernal, A. Álvarez Álvarez, JM. Pérez-Pariente, et al. Changes in Incidence of inflammatory bowel disease during the Last 15 years: A epidemiological prospective Population-Based Study from Gijón (Spain), (1992-2006). Gut 2007;39(Suppl 1):A129.
27. Arin Letamendia A, Borda Celaya F, Burusco Paternain MJ, Prieto Martínez C, Martínez Echeverría A, Elizalde Apestegui I, et al. High incidence rates of inflammatory bowel disease in Navarra (Spain). Results of a prospective, population-based study. Gastroenterol Hepatol 2008;31:111-116.
28. Garrido A, Martinez MJ, Ortega JA, Lobato A, Rodriguez MJ, Guerrero FJ. Epidemiology of chronic inflammatory bowel disease in the northern area of Huelva. Rev Esp Enferm Dig 2004;96:687-691. (Pubitemid 39585700)
29. Rodrigo L, Riestra S, Niño P, Cadahia V, Tojo R, Fuertes D, et al. A population-based study on the incidence of inflammatory bowel disease in Oviedo (Northern Spain). Rev Esp Enferm Dig 2004;96:291-296. (Pubitemid 38979198)
30. Rivera Irigoín R, de Sola Earle C, Ubiña Aznar E, Perea-Milla E, Fernández Pérez F, Navarro Jarabo JM, et al. Incidence and clinic-epidemiological aspects of ulcerative colitis in the area of the Hospital Costa del Sol. Gastroenterol Hepatol 2007;30:7-10. (Pubitemid 46238619)
31. Haug K, Schrumpf E, Barstad S, Fluge G, Halvorsen JF. Epidemiology of Ulcerative Colitis in western Norway. Scand J Gastroenterol 1988;23:517-522. (Pubitemid 18165986)
32. Kildebo S, Nordgaard K, Aronsen O, Breckan R, Burhol PG, Jorde R. The incidence of Ulcerative Colitis in Northern Norway from 1983-1986. Scand J Gastroenterol 1990;25:890-896.
33. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-1993. Scand J Gastroenterol 1996;31:362-366.
34. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-1993. Scand J Gastroenterol 1996;31:355-361.
35. Haug K, Schrumpf E, Halvorsen JF, Fluge G, Hamre E, Hamre T, et al. Epidemiology of Crohn's Disease en western Norway. Study group of Inflammatory Bowel Disease in Western Norway. Scand J Gastroenterol 1989;24:1271-1275.
36. Trallori G, Palli D, Saieva C, Bardazzi G, Bonanomi AG, d'Albasio G, et al. A population-based study of Inflammatory Bowel Disease in Florence over 15 years (1978-1992). Scand J Gastroenterol 1996;31;892-899.
37. Sood A, Midha V, Sood N, Bhatia AS and Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003;52:1587-1590. (Pubitemid 37363442)
38. Lakatos L, Mesteer G, Erdelvi Z, et al. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroetnterol 2004;10:404-409.
39. Gearry RB, Richardson A, Frampton CM, Collet JA, Burt MJ, Chapman BA, et al. High incidence of Crohn's disease in Cancterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006;12:936-943.
40. Rubin GP, Hungin AS, Kelli P, Ling J. Epidemiological features of Inflammatory Bowel Disease in the North of England. Gastroenterology 1996;110:A1004.
41. Lapidus A. Crohn's disease in Stockholm County during 1990-2001: an epidemiological update. World J Gastroenterol 2006;12:75-81.
42. Daiss W, Scheurlen M, Malchov H. Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol 1989;24:39-43. (Pubitemid 20015821)
43. Torres EA, De Jesús R, Pérez CM, Inesta M, Torres D, Morell C, et al. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996. P R Health Sci J 2003;22:253-258.
44. Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 2003;15:1275-1280. (Pubitemid 39049669)
45. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002;16:51-60. (Pubitemid 34123864)
46. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000;12:31-33.
47. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992;33:687-693.
48. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999;94:2918-2922.
49. Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:543-546. (Pubitemid 29257789)
50. Roth MP, Petersen GM, McElree C, Feldman E, Rotter JI. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989;97:900-904. (Pubitemid 19239027)
51. Ekbom A, Helmick CG, Zack M, Holmberg L, Adami HO. Survival and causes of death in patients with inflammatory bowel disease: a population based study. Gastroenterology 1992;103:954-960.
52. Munkholm P, Langholz E, Davidsen M, Binder V. Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 1993;105:1716-1723. (Pubitemid 24002788)
53. Probert CS, Jayanthi V, Wicks AC, Mayberry JF. Mortality in patients with ulcerative colitis in Leicestershire, 1972-1989. An epidemiological study. Dig Dis Sci 1993;38:538-541.
54. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Clinical course during de first year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective, population-based study in south-eastern Norway, 1990-1993. Scand J Gastroenterol 1997;32:1005-1112.
55. Witte J, Shivananada J, Lennard-Jones E, Beltrami M, Politi A, Bonanomi E, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 196-person inception cohort in the European collaborative study on inflammatory bowel disease (ECIBD). Scand J Gastroenterol 2000;35:1272-1277. (Pubitemid 32051641)
56. Jess T, Loftus EC Jr, Harmsen WS, Zinsmeister AR, Tremaine WJ, Maletón LJ 3rd, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006;55:1248-1254.
57. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in diseases activity over years. Gastroenterology 1994;107:3-11. (Pubitemid 24195339)
58. Ekbom A, Helmick ZC, Zack M, et al. Ulcerative Colitis and colorectal cancer. A population-based study. New Eng J of Med 1990;323:1228-1233. (Pubitemid 20366527)
59. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-535. (Pubitemid 32234798)
60. Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large bowel cancer in Crohn's disease with colonic involvement. Lancet 1990;336:357-359. (Pubitemid 20264156)
61. Gillen CD, Andrews HA, Prior P, Allan RN. Crohn's disease and colorectal cancer. Gut 1994;35:651-655.
62. Logan R. Epidemiological overview of inflammatory bowel disease. In: Allan RN, Rhodes JM, Hanauer SB, Keighley MR, Alexander-Williams J, Fazio VW, eds. Inflammatory bowel disease. Edinburgh: Churchill Livingstone; 1997.p47-52.
63. Russel M and Stockbrugger R. Epidemiology of inflammatory bowel disease: An update. Scand J Gastroentrol 1996;31:417-427. (Pubitemid 26153633)
64. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-996.
65. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jarnerot G. Inflammatory bowel disease in a Swedish twin cohort: a longterm follow- up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-1773. (Pubitemid 36666773)
66. Orholm M, Binder V, Sorensen TI, Rasmussen LP and Kyvik KO. Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. Scand J Gastroenterol 2000;35:1075-1081. (Pubitemid 30836260)
67. Thompson NP, Driscoll R, Pounder RE, Wakefield AJ. Genetics versus enviromental factors in inflammatory bowel disease: results of a British twin study. Med J 1996;312:95-96. (Pubitemid 26015449)
68. Satsangi J, Rosenberg WMC, Jewell DP. The prevalence of inflammatory bowel disease in relatives of patients with Croh's disease. Eur J Gastroenterol Hepatol 1994;6:413-416. (Pubitemid 24124572)
69. Probert CS, Jayanthi V, Hughes AO, Thompson JR, Wicks AC, Mayberry JF. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and South Assians in Leicestershire. Gut 1993; 34:1547-1551. (Pubitemid 23341846)
70. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen I, Binder V. Familial occurrence in inflammatory bowel disease. N Eng J Med 1991;324:84-88.
71. Freeman HJ. Familial Crohn's disease in single or multiple fi rst-degree relatives. J Clin Gastroenterol 2002;35:9-13.
72. Halme L, Turunen U, HelioT Paavola P, Walle T, Miettinen A, Jarvinen H, et al. Familial and sporadic inflammatory bowel disease: comparison of clical features and serological markers in a genetically homogeneous population. Scand J Gastroenterol 2002;37:692-698. (Pubitemid 34620932)
73. Carbonnel F, Macaigne G, Beaugerie L, Gendre JP, Cosnes J. Crohn's disease severity in familial and sporadic cases. Gut 1999;44:91-95. (Pubitemid 29143286)
74. Peeters M, Nevens H, Baert F, Hiele M, de Meyer AM, Vlietinck R, Rutgeers P. Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. Gastroenterology 1996;111:597-603. (Pubitemid 26293222)
75. Bayless TM, Tokayer AZ, Polito JM 2nd, Quaskey SA, Mellits ED, Harris ML. Crohn's disease: concordance for site and clinical type in affected family members - potential hereditary influences. Gastroenterology 1996;111:573-579.
76. Yang H, McElree C, Roth MP Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993;34:517-524. (Pubitemid 23093496)
77. Mathew C.G. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nature 2008;9:9-13.
78. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. (Pubitemid 32531408)
79. Ogura Y, Bonen DK, Inohara N, Nikolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606. (Pubitemid 32531409)
80. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD mutational analysis and genotiype/phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002;70:815-857. (Pubitemid 34259301)
81. Hampe J, Schreiber S, Shaw SH, et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999;64:808-1801 (Pubitemid 30460424)
82. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, et al. Functional variants of OCTN cation transporter genes are associated with Crohn's disease. Nat Genet 2004;36:471-475. (Pubitemid 38620030)
83. Mendoza JL, Urcelay E, Lana R, Martínez A, Taxonera C. de la Concha EG, et al. Polimorphisms in interleukin-10 gene according to mutations of NOD2/CARD15 gene and relation to phenotipe in spanish patients cith Crohn's disease. World J Gastroenterol 2006;12:443-448. (Pubitemid 43329263)
84. Botstein D and Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33:228-237. (Pubitemid 36278833)
85. Miad SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006;81:1462-1471. (Pubitemid 44687433)
86. Bridger S, Lee J, Bjarnason I, Lennard Jones JE, Macpherson AJ. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 2002;51:21-25.
87. Harries AD, Jones L, Heatley RV, Rhodes J. Smoking habits and inflammatory bowel disease: effect in nutrition. Br Med J 1982;284:1161.
88. Logan R. Smoking and inflammatory bowel disease-an overview of recent studies. In: MacDermott RP, ed. Inflammatory bowel disease: current status and future approach. New York: Elsevier Science Publishers; 1988.p663-669.
89. Sicilia B, Arribas F, Nerín J, López-Miguel C, Vicente R, and Gomollón F. Risk Factors for ulcerative coliits: A population-based case-control study in Spain. Journal of Crohn's and colitis 2008:158-161. (Pubitemid 351672124)
90. Silverstein MD, Lashner BA, Hanauer SB. Cigarette smoking and ulcerative colitis: a case-control study. Mayo Clin Proc 1994;69:425-429. (Pubitemid 24132684)
91. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-1854. (Pubitemid 20018648)
92. Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke: a case-control study. Gut 1990;31;1377-1381.
93. Boyko EJ, Perera DR, Koepsell TD, et al. Risk of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988;316:707-710.
94. Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP and Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001;96: 2113-2116. (Pubitemid 32660906)
95. Regueiro M, Kip KE, Cheung O, Hegazi RA, Plevy S. Cigarette Smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis 2005;11:42-47.
96. Rhosdes J. Thomas GAO. Smoking good or bad for inflammatory bowel disease? Gastroenterology 1994;106:807-809.
97. Galeazzi F, Blennerhassett PA, Qiu P, O'Byrne PM, Collins SM. Cigarette smoking aggravates experimental colitis in rats. Gastroenterology 1999;117:877-883. (Pubitemid 29468230)
98. Cosnes J, Carbonel F, Beaugerie L, LeQuintrec Y and Gendre J-P. Effects of cigarette smoking on the long term course of Crohn's disease. Gastroenterology 1996;110:424-431. (Pubitemid 26043875)
99. Sutherland LR, Ramcharan S, Bryant H and Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123-1128. (Pubitemid 20143093)
100. Lindberg E, Järnerot G and Huitfeldt B. Smoking in Crohn's disease: effect on localization and clinical course. Gut 1992;33:779-782.
101. Timmer A, Sutherland LR, Martin F and the Canadian mesalamine for remission of Crohn's disease study group. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. Gastroenterology 1998;114:1143-1150.
102. Sicilia B, López Miguel C, Arribas F, López Zaborras J, Sierra E and Gomollón F. Environmental risk factors and Crohn's Disease: a population-based, case-control study in Spain. Dig Liver Dis 2001;33:762-767. (Pubitemid 34071467)
103. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's Disease. Gastroenterology 1994;106:643-648. (Pubitemid 24064330)
104. Koutroubakis IE, Vlachonikolis IG. Appendectomy and the development of ulcerative colitis: results of a meta-analysis of published case-control studies. Am J Gastroenterol 2000;95:171-176.
105. Radford Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002;51:808-1803
106. Godet PG, May R, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668-673.
107. Boyko EJ, Theis MK, Vaughan TL, Nicol-Blades B. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol 1994;140:268-278. (Pubitemid 24231913)
108. Corrao G, Tragnone A, Caprilli R, et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy - a nationwide case-control study. Intl J Epidemiol 1998;27:397-404. (Pubitemid 28336965)
109. Alic M. Epidemiology supports oral contraceptives as a risk factor in Crohn's disease. Gut 2000;46:140-142. (Pubitemid 30307693)
110. Taurog JD, Hammer RE, Montafiez S et al. Effect of germen free state on the inflammatory bowel disease of HLAB-27 transgenic rats. Arthritis and Rheumatism 1993;36:S46 (Abstract no45).
111. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of an adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-421. (Pubitemid 39091889)
112. Bernstein CN, Blanchard JF, Rawsthorne P and Collins MT. Population-based case-control study of seroprevalence of Mycobacterium tuberculosis in patients with Crohn's disease and ulcerative colitis. J Clin Microbiol 2004:1129-1135. (Pubitemid 38332836)
113. Bentley RW, Keenan JI, Gearry RB, Kennedy MA, Barclay ML, Roberts RL. Incidence of Mycobacterium avium subspecies paratuberculosis in a population-based cohort of patients with Crohn's disease and control subjects. Am J Gastroenterol 2008;103:1168-1172.
114. Mayberry JF, Rhodes J, Allan R, et al. Diet in Crohn's disease. Dig Dis Sci 1981;26:244-248.
115. Panza E, Franceschi S, La Vecchia C, et al. Dietary factors in the etiology of inflammatory bowel disease. Ital J Gastroenterol 1987;19:205-209. (Pubitemid 17024134)
116. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992;3:47-52.
117. Reif S, Klein F, Lubin F, Farbstein M, Hallak A and Gilat T. Pre-illness dietary risk factors in inflammatory bowel disease. Gut 1997;40:754-760. (Pubitemid 27305468)
118. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005;11:154-163. (Pubitemid 40711220)
119. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-767. (Pubitemid 24098696)
120. García Rodríguez LA, González Pérez A, JohanssonS, and Wallander MA. Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther 2005;22:309-315. (Pubitemid 41207460)
121. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: A critical review of the literature. World J Gastroenterol 2008;14:165-173. (Pubitemid 351314294)
122. Bjarnason I, Zanelli G, Smith T, et al. Nonsteroideal anti-Inflammatory drugs induced intestinal inflammation in humans. Gastroenterology 1987;93:480-489.
123. Forrest K, Symmons D, Foster P. Systematic review: is ingestion of paracetamol and non-steroideal antiinflammatory drugs associated with exacerbations of inflammatory bowel disease? Aliment Pharmacol Ther 2004;20:1035-1043.